State-of-the-Art Speakers have been announced for the 2014 World Transplant Congress!
Dr. Eric Schadt will present his State-of-the-Art presentation on Monday, July 28, 2014.
Eric Schadt, PhD, is Director of the Icahn Institute for Genomics and Multiscale Biology, Chair of the Department of Genetics and Genomics Sciences, and the Jean C. and James W. Crystal Professor of Genomics at the Icahn School of Medicine at Mount Sinai.
Dr. Schadt is an expert on the generation and integration of very large-scale sequence variation, molecular profiling and clinical data in disease populations for constructing molecular networks that define disease states and link molecular biology to physiology. He is known for calling for a shift in molecular biology toward a network-oriented view of living systems to complement the reductionist, single-gene approaches that currently dominate biology in order to more accurately model the complexity of biological systems. He has published more than 200 peer-reviewed papers in leading scientific journals, and contributed to a number of discoveries relating to the genetic basis of common human diseases such as diabetes, obesity, and Alzheimer’s disease.
Prior to joining Mount Sinai in 2011, he was Chief Scientific Officer at Pacific Biosciences. Previously, Dr. Schadt was Executive Scientific Director of Genetics at Rosetta Inpharmatics, a subsidiary of Merck & Co., and before Rosetta, Dr. Schadt was a Senior Research Scientist at Roche Bioscience. He received his B.A. in applied mathematics and computer science from California Polytechnic State University, his M.A. in pure mathematics from University of California, Davis, and his Ph.D. in bio-mathematics from University of California, Los Angeles (requiring Ph.D. candidacy in molecular biology and mathematics).
Dr. Alvin Roth will present his State-of-the-Art presentation on Tuesday, July 29, 2014.
Al Roth is the Craig and Susan McCaw Professor of Economics at Stanford University, and the Gund Professor Emeritus of Economics and Business Administration at Harvard. He is one of the founders of the field of market design, for which he shared the 2012 Nobel Economics prize. He has worked on kidney exchange for over a decade.
Dr. Shinya Yamanaka will present his State-of-the-Art presentation on Wednesday, July 30, 2014.
Professor Shinya Yamanaka received his M.D. from Kobe University in 1987 and a Ph.D. from Osaka City University Graduate School in 1993. After working as a postdoctoral fellow at the Gladstone Institute of Cardiovascular Disease in San Francisco, he became an assistant professor at Osaka City University in 1996. He was appointed as an associate professor at the Nara Institute of Science and Technology in 1999, and a professor in 2003. He moved to Kyoto University in 2004, and since 2008, Yamanaka serves as the director of the Center for iPS Cell Research and Application (CiRA) at Kyoto University. He has received awards including “Albert Lasker Basic Medical Research Award” in 2009, “Imperial Prize and Japan Academy Prize” in 2010, “Kyoto Prize” in 2010, and “Wolf Prize’’ in 2011, and “Nobel Prize in Physiology or Medicine” in 2012. He also serves as a senior investigator at Gladstone and is a foreign associate of the U.S. National Academy of Sciences.